M2 PRESSWIRE-August 29, 2019-: Nanomedicine
Market To Gain Tremendous Demand on Account of Significant Applications in Prophylaxis of Acute And Chronic Diseases Till 2025 | Million Insights
Addressing the gathering titled 'Nanomedince current scenario and future perspectives', former vice chancellor of the University of Veterinary and Animal Sciences Muhammad Nawaz said on Tuesday they could not ignore the importance of nanomedicine
in achieving healthcare goals.
The overall objective of expert is to create an off-the-shelf mrna-delivering nanomedicine
platform that is manufactured via a quality-by-design (qbd) approach with precise nanoparticle characterization and specifications that meet the requirements for gmp scaling up and clinical translation.
for the Treatment of Disease: From Concept to Application
M2 EQUITYBITES-June 12, 2019-Costas Acquires Atlas Nanotech to Enter Nanomedicine
In 2017, Cytori acquired a nanomedicine
platform technology that combines the chemotherapy agents doxorubicin and docetaxel with liposomal encapsulation technology.
Published in PNAS on February 11, 2019, this work may explain the presence of "natural" magnetism in human cells, and help us to envisage new tools for nanomedicine
, thanks to this magnetism produced by the cells themselves.
We are excited to work with PNI to offer their purpose-designed manufacturing technology and unique nanomedicine
expertise to our clients for the manufacture of nanoparticle-based medicines" said Kristin DeFife, Ph.D., vice president and head of U.S.
The company added that CPI-100 is a structurally optimal core-shell nanoparticles based on its proprietary nanoscale coordination polymer (NCP) platform technology to selectively deliver immunostimulatory chemotherapeutic combinations to tumors, providing a new approach to initiate and stimulate immune-mediated eradication of cancer cells using synergistic nanomedicines
. CPI-100, a Novel Antitumor Nanomedicine
M2 PHARMA-October 8, 2018-FDA Grants Coordination Pharmaceuticals IND Approval for CPI-100, a Novel Antitumor Nanomedicine
"We have discovered an environmental and pathogenic origin of chronic intestinal inflammation in the course of modeling human food poisoning as it occurs repeatedly over the adult lifespan," explains Jamey Marth, director of the Center for Nanomedicine
at the University of California, Santa Barbara, and professor at the Sanford Burnham Pre-bys Medical Discovery Institute, La Jolla.
JEDDAH: Adah Almutairi, who holds more than 10 patents in the field of nanomedicine
, is a Saudi scholar and entrepreneur.